États-Unis - anglais - NLM (National Library of Medicine)

sincerus florida, llc - fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m), minoxidil (unii: 5965120sh1) (minoxidil - unii:5965120sh1), progesterone (unii: 4g7ds2q64y) (progesterone - unii:4g7ds2q64y) -

États-Unis - anglais - NLM (National Library of Medicine)

sincerus florida llc - fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4) -

États-Unis - anglais - NLM (National Library of Medicine)

sincerus florida llc - fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4) -

États-Unis - anglais - NLM (National Library of Medicine)

sincerus florida, llc - fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m), minoxidil (unii: 5965120sh1) (minoxidil - unii:5965120sh1), tretinoin (unii: 5688utc01r) (tretinoin - unii:5688utc01r) -

États-Unis - anglais - NLM (National Library of Medicine)

a-s medication solutions - fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m) - fluocinolone acetonide topical oil, 0.01% is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. this product contains refined peanut oil nf (see precautions section). pediatric use: fluocinolone acetonide topical oil, 0.01% may be used twice daily for up to 4 weeks in pediatric patients 2 years and older with moderate to severe atopic dermatitis.  fluocinolone acetonide topical oil, 0.01% should not be applied to the diaper area. application to intertriginous areas should be avoided due to the increased possibility of local adverse events such as striae, atrophy, and telangiectasia, which may be irreversible. the smallest amount of drug needed to cover the affected areas should be applied. long term safety in the pediatric population has not been established. fluocinolone acetonide topical oil, 0.01% is not recommended for use on the face (see adverse reactions section). because of a higher ratio of skin surface area to body mass, children are at

États-Unis - anglais - NLM (National Library of Medicine)

arbor pharmaceuticals - ciprofloxacin (unii: 5e8k9i0o4u) (ciprofloxacin - unii:5e8k9i0o4u), fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m) - ciprofloxacin 872.5 ug in 0.25 ml - otovel is indicated for the treatment of acute otitis media with tympanostomy tubes (aomt) in pediatric patients (aged 6 months and older) due to staphylococcus aureus, streptococcus pneumoniae, haemophilus influenzae, moraxella catarrhalis, and pseudomonas aeruginosa . otovel is contraindicated in: - patients with known hypersensitivity to fluocinolone acetonide or other corticosteroids, ciprofloxacin or other quinolones, or to any other components of otovel. - viral infections of the external ear canal, including varicella and herpes simplex infections and fungal otic infections. risk summary otovel is negligibly absorbed following otic administration and maternal use is not expected to result in fetal exposure to ciprofloxacin and fluocinolone acetonide [see clinical pharmacology (12.3) ]. risk summary otovel is negligibly absorbed by the mother following otic administration and breastfeeding is not expected to result in exposure of the infant to ciprofloxacin and fluocinolone acetonide [see clinical phar

États-Unis - anglais - NLM (National Library of Medicine)

wraser llc - ciprofloxacin (unii: 5e8k9i0o4u) (ciprofloxacin - unii:5e8k9i0o4u), fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m) - otovel is indicated for the treatment of acute otitis media with tympanostomy tubes (aomt) in pediatric patients (aged 6 months and older) due to staphylococcus aureus , streptococcus pneumoniae , haemophilus influenzae , moraxella catarrhalis , and pseudomonas aeruginosa . otovel is contraindicated in: - patients with known hypersensitivity to fluocinolone acetonide or other corticosteroids, ciprofloxacin or other quinolones, or to any other components of otovel. - viral infections of the external ear canal, including varicella and herpes simplex infections and fungal otic infections. risk summary otovel is negligibly absorbed following otic administration and maternal use is not expected to result in fetal exposure to ciprofloxacin and fluocinolone acetonide [see clinical pharmacology (12.3)]. risk summary otovel is negligibly absorbed by the mother following otic administration and breastfeeding is not expected to result in exposure of the infant to ciprofloxacin and fluocinolone acetonide [ see clinical pharmacology (12.3) ]. otovel has been studied in patients as young as 6 months in adequate and well-controlled clinical trials. no major differences in safety and effectiveness have been observed between adult and pediatric patients [ see indications and usage (1)and dosage and administration (2)]. clinical studies of otovel did not include sufficient numbers of subjects aged 65 years and over to determine whether they respond differently from younger subjects. other reported clinical experience has not identified differences in responses between the elderly and younger patients. read this instructions for use that comes with otovel before you start using it and each time you get a refill. there may be new information. this information does not take the place of talking with your healthcare provider about your medical condition or treatment. important information about otovel : - otovel is for use in the ear only (otic use) . do not inject otovel or use otovel in the eye. - use otovel solution exactly as your healthcare provider tells you to use it. how should i use otovel? this instructions for use has been approved by the food and drug administration.

États-Unis - anglais - NLM (National Library of Medicine)

sincerus florida, llc - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987), fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m) -

Philippines - anglais - FDA (Food And Drug Administration)

euro-med laboratories phil., inc. - fluocinolone acetonide - cream - each g contains 250 mcg fluocinolone acetonide

États-Unis - anglais - NLM (National Library of Medicine)

zoetis inc. - fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m), dimethyl sulfoxide (unii: yow8v9698h) (dimethyl sulfoxide - unii:yow8v9698h) - synotic otic solution veterinary is indicated for the relief of pruritus and inflammation associated with acute and chronic otitis in the dog.